From Milwaukee to the Hollywood Hair Institute
Ashley Zsaton, DNP, ACNP-AG, didn’t choose hair science because it was a growing industry. She chose it because people told her, from childhood, that her own hair was wrong.
Growing up biracial in Milwaukee, Zsaton wasn’t always welcomed for wearing her natural curls. The comments weren’t always harsh – sometimes they came wrapped in the language of preference, of what looked “professional” or “neat.” But the underlying message was consistent: her hair, as it grew from her scalp, needed to be managed, tamed, or explained. Rather than accept that framework, she started pulling it apart. What did “good hair” actually mean? Where did those standards come from, and who decided? Those questions, which most people either absorb or dismiss, sent her toward medicine.
Today, Zsaton is co-founder of the Hollywood Hair Institute, California’s preeminent hair transplant and aesthetic treatment center, where she works as a board-certified nurse practitioner and hair loss specialist. Her path there was not linear. Before hair, she worked in critical care – supporting patients in the ICU – and in ophthalmology, where her research contributed to a nationally published school-based vision screening program. The medical rigor she built in those environments now informs how she approaches scalp health and hair restoration, where the clinical stakes are quieter but the emotional ones are not.
A significant turning point came before her medical career, during a period she spent in the Dominican Republic. Surrounded by a population where curly hair was styled and cared for across a wide range of textures and methods – not flattened or hidden – Zsaton saw what a different cultural relationship with natural hair actually looked like in practice. She brought that perspective back to the United States, and when her husband encouraged her to channel her interest in scalp care toward medical aesthetics, the direction clicked.
Her background is worth understanding in full because it shapes how she treats patients. Zsaton isn’t approaching hair loss as a purely cosmetic inconvenience. She’s operating at the intersection of identity, medicine, and the kind of damage that builds slowly over years of hairstyling choices people never thought to question.
What Hair Restoration Actually Involves – And What It Doesn’t
In a recent conversation with host Brooke Devard on the Nkaed Beauty podcast, Zsaton walked through the full spectrum of hair restoration treatments – and was specific about what each one does, who qualifies, and where the limits are. The conversation covered Platelet-Rich Plasma therapy (PRP), Follicular Unit Extraction (FUE), and Minoxidil, among others. Zsaton didn’t frame these as a tiered menu from least to most serious. She framed them as tools with distinct indications, and being a good surgical candidate for one doesn’t mean you’re a good fit for another.
Follicular Unit Extraction is the surgical option – individual hair follicles harvested from a donor area and transplanted to areas of thinning or loss. The candidate profile matters enormously here. A patient needs adequate donor density, stable hair loss, and realistic expectations about what transplanted hair will and won’t do. Zsaton walked Devard through what that profile looks like, and what disqualifies someone from surgery in favor of non-surgical alternatives. This kind of specificity is rarely part of public conversations about hair transplants, which tend to be filtered through before-and-after images rather than clinical criteria.
PRP – Platelet-Rich Plasma – involves drawing a patient’s own blood, processing it to concentrate the platelets, and injecting that concentrate into the scalp. The mechanism is rooted in the growth factors platelets carry, which can stimulate follicle activity. It’s not a permanent fix, and it works better for some types of hair loss than others. Minoxidil, the topical and oral treatment that has been available for decades, remains one of the most consistently effective options for androgenetic alopecia in both men and women, though Zsaton is clear-eyed about its limitations – it requires ongoing use, and results vary.
What made the podcast conversation notable was the segment where Devard shared her own experience. Zsaton had prepared a specific routine for her, and Devard reported back on how effective each product had been in growing her hair. That kind of real-world follow-through – a practitioner building a protocol for a specific person and that person documenting results publicly – is rare in a space that’s often heavy on product claims and light on accountability. It doesn’t prove universal efficacy, but it does model what an individualized approach actually looks like when it’s put into practice.
The discussion also covered traction alopecia in some depth. This is the hair loss caused by repeated tension on the follicle – the kind that builds from tight braids, weaves, ponytails, and extensions worn consistently over time. Zsaton didn’t frame this as a problem exclusive to women or to any particular hair type. Men who wear tight cornrows or frequently style hair under tension are equally vulnerable. The damage accumulates gradually, which is part of why it’s so often caught late. By the time the hairline starts receding visibly, the follicle may have been under stress for years.
Traction alopecia is, in many cases, preventable – but prevention requires information that isn’t routinely offered in salons or passed down culturally, particularly in communities where protective styles are a practical and aesthetic staple. Zsaton’s position is that protective styles aren’t inherently damaging; the problem is application, tension, duration, and whether the scalp is getting breaks between styles. The distinction matters because the reflex to avoid all braids or weaves entirely isn’t the answer – and it would erase styling practices that carry real cultural weight.
The Long Work of Changing Who Gets Access
Zsaton’s work at the Hollywood Hair Institute is, at its core, about access. Hair restoration has historically been marketed toward a narrow demographic – older white men experiencing male-pattern baldness – and the clinical research base reflects those priorities. Treatments like FUE have expanded considerably, but the populations who know they’re candidates, or who feel welcome in consultation rooms, haven’t kept pace with the technology.
That gap is where Zsaton’s particular background becomes relevant again. A trichologist who grew up navigating hair politics as a biracial woman in Milwaukee, who spent time in the Dominican Republic watching curly hair treated with fluency rather than suspicion, and who later built a career in critical care and ophthalmology before turning to scalp medicine – she is not approaching hair loss through the same lens as the industry default. Whether that difference reaches the patients who need it most depends on whether conversations like the one she had with Brooke Devard keep happening, and whether the people who’ve been told their hair is a problem keep asking who actually benefits from that idea.
